New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - dihydroergotamine mesilate 1 mg/ml - solution for injection - 1 mg/ml - active: dihydroergotamine mesilate 1 mg/ml

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - dihydroergotamine mesilate 1mg - tablet - 1 mg - active: dihydroergotamine mesilate 1mg

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - dihydroergotamine mesilate 2.5mg - tablet - 2.5 mg - active: dihydroergotamine mesilate 2.5mg

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - dihydroergotamine 0.714 mg/ml; heparin 7142.8 iu/ml; lidocaine 10.66 mg/ml - solution for injection - 0.7 ml - active: dihydroergotamine 0.714 mg/ml heparin 7142.8 iu/ml lidocaine 10.66 mg/ml

Israel - English - Ministry of Health

sanofi - aventis israel ltd - roxithromycin - film coated tablets - roxithromycin 150 mg - roxithromycin - for the treatment of infections caused by microorganisms sensitive to roxithromycin e.g: ent bronchopulmonary, genital and skin manifestations.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - dihydroergotamine mesylate - tablets - 2.5mg - antimigraine preparations

Ireland - English - HPRA (Health Products Regulatory Authority)

polichem s.a. - dihydroergotamine mesilate - tablets - 20 milligram

Bahrain - English - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

yousif mahmood hussain & bahrain pharmacy co - dihydroergotamine mesylate - nasal spray - 4

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

amdipharm ltd. - dihydroergotamine mesilate 2,5 mg - tablet - dihydroergotamine

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

morningside healthcare ltd - clarithromycin - modified-release tablet - 500mg